Tarsus Pharmaceuticals, Inc. recently disclosed the latest progress on its leading vaccine candidate under development for Lyme disease.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to the company's plan, patient recruitment for the candidate vaccine is expected to be fully completed during the tick-active season in 2026. The timing aligns with the peak period of Lyme disease transmission, ensuring that the clinical trial can thoroughly evaluate the vaccine's protective efficacy under real-world conditions. Immediately after recruitment is finished, the research team will enter an intensive phase of data collection and statistical analysis. The company has clearly stated that the key topline results of this project are anticipated to be released to the public in the first half of 2027. These results will reveal, for the first time, the performance of the vaccine in critical efficacy endpoints and are drawing significant market attention. If the data is positive, it will provide a solid foundation for subsequent applications to regulatory authorities and is expected to address major unmet medical needs in the field of Lyme disease prevention.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
BrightView's Operational Improvements Seen Driving Financial Growth, Oppenheimer Says
MT newswire•2026/09/24 15:47
AGF Management Ltd. Price Target Cut to C$19.00/Share From C$21.00 by BMO
Dow Jones•2026/09/24 15:45
BlackBerry Trims Secure Communications Forecast as Precaution -- Market Talk
Dow Jones•2026/09/24 15:36
IRLAB names Janne Backman board chair, replacing Carola Lemne
Bitget•2026/09/24 15:33
Crypto prices
MoreBitcoin
BTC
$84,313.3
+0.03%
Ethereum
ETH
$2,679.33
+0.67%
Tether USDt
USDT
$0.9995
-0.04%
BNB
BNB
$779.39
+1.67%
XRP
XRP
$1.51
-0.10%
USDC
USDC
$0.9997
-0.02%
Solana
SOL
$116.14
+1.48%
TRON
TRX
$0.3398
+0.05%
Zcash
ZEC
$1,519.44
-3.34%
Hyperliquid
HYPE
$93.45
-0.11%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now